Jim Simons
BLRX

Jim Simons’s BioLineRX BLRX Stock Holding History

Jim Simons’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,468
Closed -$157K – 3681
2023
Q2 		$157K Sell
2,468
-184
-7% -$10.2K ﹤0.01% 3350
2023
Q1 		$94K Sell
2,652
-3,796
-59% -$99.8K ﹤0.01% 3508
2022
Q4 		$152K Buy
6,448
+4,742
+278% +$141K ﹤0.01% 3502
2022
Q3 		$63K Buy
1,706
+562
+49% +$32.1K ﹤0.01% 3702
2022
Q2 		$59K Sell
1,144
-540
-32% -$30K ﹤0.01% 3965
2022
Q1 		$115K Buy
1,684
+1,331
+377% +$92.7K ﹤0.01% 3768
2021
Q4 		$29K Sell
353
-72
-17% -$7.51K ﹤0.01% 3823
2021
Q3 		$47K Sell
425
-1,520
-78% -$180K ﹤0.01% 3376
2021
Q2 		$219K Sell
1,945
-10,683
-85% -$1.26M ﹤0.01% 3228
2021
Q1 		$1.41M Buy
12,628
+5,953
+89% +$716K ﹤0.01% 2433
2020
Q4 		$673K Sell
6,675
-7
-0.1% -$612 ﹤0.01% 2690
2020
Q3 		$438K Buy
6,682
+2,748
+70% +$208K ﹤0.01% 2862
2020
Q2 		$269K Buy
+3,934
New +$269K ﹤0.01% 3078
2019
Q1 		– Sell
-102
Closed -$27K – 3455
2018
Q4 		$27K Buy
+102
New +$49.1K ﹤0.01% 3314
2018
Q2 		– Sell
-374
Closed -$195K – 3264
2018
Q1 		$195K Sell
374
-351
-48% -$215K ﹤0.01% 3182
2017
Q4 		$474K Buy
725
+275
+61% +$181K ﹤0.01% 2901
2017
Q3 		$303K Buy
+450
New +$280K ﹤0.01% 2898
2017
Q2 		– Sell
-219
Closed -$126K – 3192
2017
Q1 		$126K Buy
+219
New +$141K ﹤0.01% 3053
2015
Q1 		– Sell
-45
Closed -$44K – 3162
2014
Q4 		$44K Sell
45
-169
-79% -$147K ﹤0.01% 2884
2014
Q3 		$197K Buy
214
+141
+193% +$151K ﹤0.01% 2555
2014
Q2 		$91K Buy
73
+28
+62% +$35K ﹤0.01% 2675
2014
Q1 		$60K Buy
45
+28
+165% +$46K ﹤0.01% 2748
2013
Q4 		$29K Sell
17
-86
-83% -$139K ﹤0.01% 2806
2013
Q3 		$135K Buy
103
+53
+106% +$62.6K ﹤0.01% 2651
2013
Q2 		$48K Buy
+50
New +$51.8K ﹤0.01% 2699

Other funds holding BLRX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Jim Simons's BLRX Position: Q3 2023 in Review

Jim Simons sold out of BioLineRX (BLRX) in Q3 2023, closing a stake of 2,468 shares — an estimated $157K sold.

Jim Simons first reported a position in BLRX in Q2 2013 and held it in 25 quarters. The position peaked at $1.41M in Q1 2021. 29 funds tracked by Wall St. Rank hold BLRX as of Q3 2023.

  • Jim Simons reported no remaining BioLineRX position as of Q3 2023 after selling out during the quarter.
  • Jim Simons sold 2,468 BioLineRX shares in Q3 2023, an estimated $157K.
  • Jim Simons first reported a position in BioLineRX in Q2 2013 and held it in 25 quarters.
  • Jim Simons's BioLineRX position peaked at $1.41M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held BioLineRX as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.